Physician profile
Hunter Fleming
NPI 1598262081
$634.40
in general payments reported to CMS, 2019-2025
14 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $233 · 2024: $299 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $195.20 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $119.26 | 2023-2025 | Euflexxa |
| Smith+Nephew, INC. | $53.66 | 2023-2024 | Stravix Pl, Pico 14, Pico 7 |
| Kerecis Limited | $46.13 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ethicon US, LLC | $32.14 | 2024 | Vistaseal, Monocryl, Stratafix |
| Ossur Americas, INC. | $28.41 | 2024 | Miami J |
| Bioventus LLC | $26.32 | 2024 | Durolane |
| Solventum Corporation | $24.09 | 2025 | Prevena |
| Sanara Medtech INC. | $23.59 | 2023 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $21.58 | 2025 | |
| Depuy Synthes Sales INC. | $18.35 | 2025 | Dynatape, Truespan Orthocord, Milagro |
| Molnlycke Health Care US, LLC | $17.77 | 2024 | Mlnlycke Z-Flex Fluidized Heel Boot, Mepilex, Mepilex Border Post-Op Ag |
| Vericel Corporation | $15.44 | 2023 | Maci |
| Nuo Therapeutics | $12.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.